Our data might have broader implications in mitigating the impact of tau pathology on vision deficits in several visual disorders by offering an innovative, alternative approach for the cure of these devastating illnesses that hardly compromise the life quality of patients affected by AD and, possibly, from other human tauopathies. Here, MAPT is linked to Alzheimer disease.